New nanoparticle treatment may provide 'immediate pain relief' for millions with rheumatoid arthritis

(STUDY FINDS) – Millions of individuals suffering from the crippling effects of arthritis may soon see relief thanks to a groundbreaking scientific discovery. Researchers in South Korea have identified new nanoparticles that show promise in treating rheumatoid arthritis. A single dose of this state-of-the-art medication has the potential to offer significant relief to patients, according…

The post New nanoparticle treatment may provide 'immediate pain relief' for millions with rheumatoid arthritis appeared first on WND.

(Unsplash)

(STUDY FINDS) – Millions of individuals suffering from the crippling effects of arthritis may soon see relief thanks to a groundbreaking scientific discovery. Researchers in South Korea have identified new nanoparticles that show promise in treating rheumatoid arthritis. A single dose of this state-of-the-art medication has the potential to offer significant relief to patients, according to lab trials involving mice.

According to the National Institutes of Health, over one million adults suffer from rheumatoid arthritis (RA) in the United States alone. RA disproportionately impacts women, affecting two to three times as many women as men. The condition most commonly develops in individuals between the ages of 40 and 60.

Get the hottest, most important news stories on the Internet – delivered FREE to your inbox as soon as they break! Take just 30 seconds and sign up for WND's Email News Alerts!

The Korean scientists believe they have devised a novel treatment strategy for RA, a condition currently without a cure. They point out that RA induces a range of troublesome symptoms, including inflamed joints, harmful cytokines, and immune system imbalances. These factors collectively contribute to a vicious cycle of escalating symptoms.

Read the full story ›

The post New nanoparticle treatment may provide 'immediate pain relief' for millions with rheumatoid arthritis appeared first on WND.